Daily Archives: February 12, 2020
NICE Guideline: Antimicrobial Prescribing for Leg Ulcer Infection
12 Feb, 2020 | 07:35h | UTCLeg ulcer infection: antimicrobial prescribing – National Institute for Health and Care Excellence (free)
Related: NICE Antimicrobial prescribing guidelines (resource covering many common conditions) AND NICE Summary of antimicrobial prescribing guidance – managing common infections (free PDF)
Related Commentary on Twitter
Using antibiotics when they're not needed means they may not work as well in the future.
Today, we've published final guidance that sets out an antimicrobial prescribing strategy for adults with leg ulcer infection.https://t.co/4UIa6VcHr8 pic.twitter.com/Wk3V93Ycp7
— NICE (@NICEComms) February 11, 2020
Wed February 12 – 10 Stories of The Day!
12 Feb, 2020 | 10:21h | UTC
1 – COVID-19: WHO Names Disease Caused by the Novel Coronavirus / SARS-CoV-2: New Designation of the Virus Itself / + Latest Articles, News & Perspectives – 12 February 2020 Edition
World Health Organization COVID-19 Situation Report:
COVID-19: WHO Names Disease Caused by the Novel Coronavirus:
- WHO Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020 – World Health Organization (free)
- Commentaries: Disease caused by the novel coronavirus officially has a name: Covid-19 – STAT (free) AND Coronavirus disease named Covid-19 – BBC (free) AND New Coronavirus Disease Officially Named COVID-19 By The World Health Organization – NPR (free) AND What’s in a Name? Why WHO’s Formal Name for the New Coronavirus Disease Matters – TIME (free)
“…we had to find a name that did not refer to a geographical location, an animal, an individual or group of people, and which is also pronounceable and related to the disease. Having a name matters to prevent the use of other names that can be inaccurate or stigmatizing. It also gives us a standard format to use for any future coronavirus outbreaks.”
SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2): International Committee on Taxonomy of Viruses Designates the Virus Itself:
“It’s official: severe acute respiratory syndrome coronavirus 2 (#SARSCoV2) causes coronavirus disease 2019 (#COVID19)” (via @TheLancetInfDis see Tweet)
Latest Articles:
- Viewpoint: Preparation for Possible Sustained Transmission of 2019 Novel Coronavirus: Lessons From Previous Epidemics – JAMA (free)
- Correspondence: On the use of corticosteroids for 2019-nCoV pneumonia – The Lancet (free)
- Special Collection: Coronavirus (2019-nCoV): evidence relevant to critical care – Cochrane Library (free articles)
- Emerging novel Coronavirus (2019-nCoV) – Current scenario, evolutionary perspective based on genome analysis and recent developments – Veterinary Quaterly (free)
Selected News & Perspectives:
- New Coronavirus Has A Name – COVID-19; But As WHO Convenes Global Research Forum Many Other Unknowns Remain – Health Policy Watch (free)
- The Best Defense Against Disturbing New Diseases – The Atlantic (free)
- Deaths from newly named coronavirus disease top 1,000 – CIDRAP (free)
- At least 500 Wuhan medical staff infected with coronavirus – South China Morning Post (free)
- The coronavirus cruise ship quarantine is a scary public health experiment – VOX (free)
- 2,000 People Are Stranded on a U.S. Cruise Ship After 4 Countries Reject Entry Over Coronavirus Fears – TIME (free)
- The First Signs Are Emerging That China’s Coronavirus Containment Could Be Working – TIME (free)
- Coronavirus Researchers Are Using High-Tech Methods to Predict Where the Virus Might Go Next – TIME (free)
- Hospitals, governments need more data to prepare for the new coronavirus outbreak – STAT (free)
- Factbox: Latest on coronavirus spreading in China and beyond – Reuters (free)
- Exclusive: Coronavirus outbreak may be over in China by April – expert – Reuters (free)
- Coronavirus may be over soon in China, expert says, as WHO warns of global threat – Reuters (free)
- Coronavirus emergency ‘holds a very grave threat’ for world: WHO – Reuters (free)
- WHO brands coronavirus ‘public enemy number one’ – Reuters (free)
- Coronavirus ‘could infect 60% of global population if unchecked’ – The Guardian (free)
- Coronavirus should be seen as ‘public enemy number one’, says WHO – The Guardian (free)
- China launches coronavirus ‘close contact detector’ app – BBC (free)
- Australian scientists grow live coronavirus virus – News Medical (free)
- How AI Is Tracking the Coronavirus Outbreak – Wired (free)
- Cruise ship coronavirus infections double, exceeding the total for any country but China – The Washington Post (free)
- There’s No Specific Drug That Kills Coronavirus. But Doctors Have Ways To Treat It – Reuters (free)
Related: NICE Antimicrobial prescribing guidelines (resource covering many common conditions) AND NICE Summary of antimicrobial prescribing guidance – managing common infections (free PDF)
News Release: New report: a roadmap to improve virtual care in Canada – Canadian Medical Association (free)
4 – Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial – JAMA (free for a limited period)
Editorial: Combination Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: Not Ready for Prime Time (free for a limited period)
Commentaries: Trial pours cold water on combo treatment for MRSA bacteremia – CIDRAP (free) AND Trial shows using two drugs not better than one when treating MRSA blood infections – University of Melbourne (free)
5 – Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock – JAMA (free for a limited period)
Editorial: Microaxial Left Ventricular Assist Devices: In Search of an Appropriate Indication (free for a limited period)
Commentary: High-tech pump may increase risk of death and bleeding, study finds – Yale News (free)
6 – Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial – The Lancet Respiratory Medicine (link to abstract – $ for full-text)
Related: Meta-Analysis: Assessment of Therapeutic Interventions and Lung Protective Ventilation in Patients with Moderate to Severe Acute Respiratory Distress Syndrome (free resources on the subject)
7 – Scrutinizing the effects of digital technology on mental health – Nature (free)
8 – Diet and Kidney Function: a Literature Review – Current Hypertension Report (free)
9 – Diagnosis and Treatment of Parkinson Disease: A Review – JAMA (free for a limited period)
Related Clinical Review Audio: Parkinson Disease (free)
Editorial: Palliative Programs for Persons With Parkinsonism—The Next Frontier (free for a limited period)
Commentaries: Palliative Care Improves Quality of Life, Symptom Burden of Patients With Parkinson Disease – AJMC (free) AND Palliative care could benefit people with Parkinson’s – OnMedica (free)
Randomized Trial: Among Patients with MRSA Bacteremia, the Addition of an Antistaphylococcal β-lactam to Standard Therapy Does Not Improve Outcomes
12 Feb, 2020 | 07:29h | UTCEffect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial – JAMA (free for a limited period)
Editorial: Combination Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: Not Ready for Prime Time (free for a limited period)
Commentaries: Trial pours cold water on combo treatment for MRSA bacteremia – CIDRAP (free) AND Trial shows using two drugs not better than one when treating MRSA blood infections – University of Melbourne (free)
Related Commentary on Twitter
Adding an antistaphylococcal β-lactam to standard #antibiotic therapy w vancomycin or daptomycin did not improve a primary composite outcome of mortality, persistent #bacteremia, relapse, or Tx failure in pts with #MRSA bacteremia https://t.co/UpyCz3Ss4F #VisualAbstract
— JAMA (@JAMA_current) February 12, 2020
Virtual Care: Recommendations for Scaling up Virtual Medical Services
12 Feb, 2020 | 07:32h | UTCVirtual care: Recommendations for Scaling up Virtual Medical Services – Canadian Medical Association (free PDF)
News Release: New report: a roadmap to improve virtual care in Canada – Canadian Medical Association (free)
[Abstract Only] Randomized Trial: Dexamethasone for the Treatment of Acute Respiratory Distress Syndrome
12 Feb, 2020 | 07:24h | UTCDexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial – The Lancet Respiratory Medicine (link to abstract – $ for full-text)
Related: Meta-Analysis: Assessment of Therapeutic Interventions and Lung Protective Ventilation in Patients with Moderate to Severe Acute Respiratory Distress Syndrome (free resources on the subject)
Related Commentary on Twitter
#Dexamethasone is associated with a substantial reduction in duration of mechanical #ventilation and all-cause 60-day #mortality in patients with #ARDS
New RCT from Jesús ViIlar and colleagues https://t.co/b4sW2K0RwG pic.twitter.com/MBbeSWBo55
— The Lancet Respiratory Medicine (@LancetRespirMed) February 10, 2020
Diet and Kidney Function: A Literature Review
12 Feb, 2020 | 07:21h | UTCDiet and Kidney Function: a Literature Review – Current Hypertension Report (free)
Observational Study: Higher Risk of Death and Major Bleeding with Intravascular Microaxial Left Ventricular Assist Device vs. Intra-aortic Balloon Pump Among Patients with Acute MI Complicated by Cardiogenic Shock
12 Feb, 2020 | 07:27h | UTCAssociation of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock – JAMA (free for a limited period)
Editorial: Microaxial Left Ventricular Assist Devices: In Search of an Appropriate Indication (free for a limited period)
Commentary: High-tech pump may increase risk of death and bleeding, study finds – Yale News (free)
Related Commentary on Twitter (Thread – Click for More)
Major paper published by @JAMA_current today that uses real-world data to examine outcomes among patients undergoing PCI for AMI who received mechanical circulatory support, comparing the Impella to IABP (and to medical therapy) (1/9) https://t.co/EsoRfSj1eH
— Joseph Ross (@jsross119) February 10, 2020
Debate: Scrutinizing the Effects of Digital Technology on Mental Health
12 Feb, 2020 | 07:23h | UTCScrutinizing the effects of digital technology on mental health – Nature (free)
Review: Diagnosis and Treatment of Parkinson Disease
12 Feb, 2020 | 07:20h | UTCDiagnosis and Treatment of Parkinson Disease: A Review – JAMA (free for a limited period)
Related Clinical Review Audio: Parkinson Disease (free)
Randomized Trial: Palliative Care Associated with Benefits Among Patients with Parkinson Disease
12 Feb, 2020 | 07:18h | UTCEditorial: Palliative Programs for Persons With Parkinsonism—The Next Frontier (free for a limited period)
Commentaries: Palliative Care Improves Quality of Life, Symptom Burden of Patients With Parkinson Disease – AJMC (free) AND Palliative care could benefit people with Parkinson’s – OnMedica (free)